COMMUNIQUÉS West-GlobeNewswire

ImpriMed Raises $4M for Customized Cancer Treatments for Dogs
12/04/2019
Precision medicine lowers the risks of treating lymphoma in dogs and eventually humans PALO ALTO, Calif., April 12, 2019 (GLOBE NEWSWIRE) -- ImpriMed, the cutting edge creator and researcher of custom, precision cancer [...]
Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social
12/04/2019
Communiqué de Presse Information relative au nombre total de droits de vote et d’actions composant le capital social Dijon, le 12 avril 2019 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]
Fin du programme de conversion des OC émises en 2018
12/04/2019
Communiqué de Presse Fin du programme de conversion des OC émises en 2018 Dijon, le 12 avril 2019 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe et commercialisera prochainement un [...]
Tauriga Sciences Inc. Proceeds with Fourth Production Run of Tauri-Gum Inventory to Support the Expansion of its Distribution Opportunities
12/04/2019
New York, NY, April 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, [...]
Better Choice Company Reverts to Trading Under the Symbol ‘BTTR’
12/04/2019
NEW YORK, April 12, 2019 (GLOBE NEWSWIRE) -- Better Choice Company, Inc (OTCQB: BTTR) (OTCQB: BTTRD) (the “Company”) today announced reverting to trading under the symbol ‘BTTR’ after temporarily trading for 20 business [...]
AXIM® Biotechnologies, Inc. Announces Attendance and Presentation by Chief Technology Officer Lekhram Changoer at Kannaway® “Believe” National Convention
12/04/2019
NEW YORK, April 12, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (“AXIM”) (“the Company”) (“AXIM ® Biotech”) (OTC: AXIM), a world leader in cannabinoid research and development, today announced the company’s [...]
Helping to Add Esophageal Adenocarcinoma to the List of Preventable Cancers
12/04/2019
- Early detection of Barrett’s esophagus and dysplasia with WATS 3D offers new solution to one of the most rapidly growing and fatal cancers in the United States - SUFFERN, N.Y., April 12, 2019 (GLOBE NEWSWIRE) -- CDx [...]
Genprex (GNPX) Featured in NetworkNewsAudio Broadcast Discussing Gene Therapy Programs on the Cusp of Curing the Incurable
12/04/2019
NEW YORK, April 12, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio -- Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio broadcast titled, “ Potential Blockbuster Gene Therapy Programs to Watch [...]
Wildflower Featured in CannabisNewsAudio Broadcast on Growing Acceptance, Soaring Sales in CBD Market
12/04/2019
NEW YORK, April 12, 2019 (GLOBE NEWSWIRE) -- via CannabisNewsAudio – Wildflower Brands Inc. (OTCQB:WLDFF) (CSE:SUN) announces the availability of a CannabisNewsAudio Publication titled, “ Increasing Growth, Acceptance [...]
Blueberries Medical to Present at 2019 GMP Securities’ Global Cannabis Conference
12/04/2019
TORONTO, April 12, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) (FRA: 1OA) (the “ Company ” or " Blueberries ") a Latin American licensed producer of medicinal cannabis and cannabis- [...]
Blissco Signs Saskatchewan Distribution and Supply Agreement with National Cannabis Distribution
12/04/2019
Not for distribution in the U.S. or to U.S. Newswires VANCOUVER, British Columbia, April 12, 2019 (GLOBE NEWSWIRE) -- Blissco Cannabis Corp. ( CSE: BLIS ) ( OTCQB: HSTRF ) ( FRA: GQ4B ), (“Blissco”) or the (“Company”) [...]
AMAG Pharmaceuticals Appoints New Members to Board of Directors
12/04/2019
WALTHAM, Mass., April 12, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the election of two new members to its Board of Directors—Anne Phillips, M.D., senior vice president, clinical [...]
Wave Life Sciences to Host Investor Conference Call to Discuss Suvodirsen DMD Clinical Data Being Presented at MDA Clinical and Scientific Conference
12/04/2019
Suvodirsen Phase 1 Safety and Tolerability Results Accepted for Oral Presentation Investor Conference Call and Webcast Scheduled for Tuesday, April 16 CAMBRIDGE, Mass., April 12, 2019 (GLOBE NEWSWIRE) -- Wave Life [...]
Rexahn Effects 1-for-12 Reverse Stock Split
12/04/2019
ROCKVILLE, MD, April 12, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical-stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers that [...]
OPKO Reports Additional Oxyntomodulin, OPK-88003, Results From Phase 2 Diabetes and Obesity Trial
12/04/2019
MIAMI, April 12, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today reported additional results from the per protocol patient population from the Phase 2 dose escalation trial of OPK-88003 to treat type 2 [...]
CymaBay Therapeutics Presents Positive Phase 2 Data for Seladelpar in Patients with Primary Biliary Cholangitis at the International Liver Congress™ 2019
12/04/2019
NEWARK, Calif., April 12, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and [...]
FameWave Announces Clinical Collaboration with Bristol Myers Squibb for the Planned Phase 1/2 Trial in Non-Small Cell Lung Cancer to Evaluate Immuno-Oncology Candidate CM-24 in Combination with Nivolumab (Opdivo®)
12/04/2019
TEL AVIV, Israel, April 12, 2019 (GLOBE NEWSWIRE) -- FameWave Ltd. a privately held biopharmaceutical company developing CM-24, which is being acquired by Kitov Pharma Ltd. (NASDAQ/TASE: KTOV), today announced the [...]
Biogen Continues to Advance Innovation in SMA with New Data in Adults and Infants to Be Presented at MDA Clinical and Scientific Conference
12/04/2019
Adults with later-onset spinal muscular atrophy (SMA) who are not being treated show increased rates of hospital admissions, clinical interventions and mortality, indicating an unmet medical need Infants with pre- [...]
Kaleido Biosciences Announces Presentation of Clinical Study and Ex Vivo Data Supporting the Development of Novel Microbiome Metabolic Therapies for Hyperammonemia at The International Liver Congress™ 2019 (EASL)
12/04/2019
LEXINGTON, Mass., April 12, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc . (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the [...]

Pages